Recent Posts

Blog, Patient Advocacy, cerebral palsy
Dr Charles Steward elected to the ICPGC GC
Posted 11th May 2021

Dr Charles Steward elected to the ICPGC GC

Read More
Blog , Patient Advocacy , genomics , SCN8A , Chapter 1
SCN8A – the needle in the haystack 
Posted 30th April 2021

SCN8A – the needle in the haystack 

Read More
Blog , Clinical Cases , genomics
Exome analysis of cases with skeletal dysplasia
Posted 28th April 2021

Exome analysis of cases with skeletal dysplasia

Read More
Blog , Clinical Cases , genomics
Automated variant classification workflows in a rare disease laboratory
Posted 28th April 2021

Automated variant classification workflows in a rare disease laboratory

Read More
News
Congenica assures the clinical safety of NHS genomic analysis
Posted 19th April 2021

Congenica assures the clinical safety of NHS genomic analysis

Read More
Blog , Patient Advocacy , epilepsy , genomics , Ring20 , Chapter 1
Redressing the balance: Ring Chromosome 20 Syndrome
Posted 16th April 2021

Redressing the balance: Ring Chromosome 20 Syndrome

Read More
News , Investor
Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia
Posted 13th April 2021

Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia

Read More
News , Blog , Patient Advocacy
Making information about genomic medicine accessible to all 
Posted 9th April 2021

Making information about genomic medicine accessible to all 

Read More
News , Investor
Congenica Appoints Jayesh Pankhania as Chief Financial Officer
Posted 6th April 2021

Congenica Appoints Jayesh Pankhania as Chief Financial Officer

Read More
Blog , epilepsy
Seeding a Life-Changing International Genomic Insight Alliance to Treat Pediatric Epilepsy
Posted 1st April 2021

Seeding a Life-Changing International Genomic Insight Alliance to Treat Pediatric Epilepsy

Read More
News , Blog
Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing
Posted 31st March 2021

Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing

Read More
previous 1 ...
2 3 4 5 6
... 18 next
Blog , Patient Advocacy , cerebral palsy
Dr Charles Steward elected to the ICPGC GC
Posted 11th May 2021

Dr Charles Steward elected to the ICPGC GC

Read More
Blog , Patient Advocacy , genomics , SCN8A , Chapter 1
SCN8A – the needle in the haystack 
Posted April Apr 30th 2021

SCN8A – the needle in the haystack 

Read More
Blog , Clinical Cases , genomics
Exome analysis of cases with skeletal dysplasia
Posted April Apr 28th 2021

Exome analysis of cases with skeletal dysplasia

Read More
Blog , Clinical Cases , genomics
Automated variant classification workflows in a rare disease laboratory
Posted April Apr 28th 2021

Automated variant classification workflows in a rare disease laboratory

Read More
News
Congenica assures the clinical safety of NHS genomic analysis
Posted April Apr 19th 2021

Congenica assures the clinical safety of NHS genomic analysis

Read More
Blog , Patient Advocacy , epilepsy , genomics , Ring20 , Chapter 1
Redressing the balance: Ring Chromosome 20 Syndrome
Posted April Apr 16th 2021

Redressing the balance: Ring Chromosome 20 Syndrome

Read More
News , Investor
Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia
Posted April Apr 13th 2021

Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia

Read More
News , Blog , Patient Advocacy
Making information about genomic medicine accessible to all 
Posted April Apr 9th 2021

Making information about genomic medicine accessible to all 

Read More
News , Investor
Congenica Appoints Jayesh Pankhania as Chief Financial Officer
Posted April Apr 6th 2021

Congenica Appoints Jayesh Pankhania as Chief Financial Officer

Read More
Blog , epilepsy
Seeding a Life-Changing International Genomic Insight Alliance to Treat Pediatric Epilepsy
Posted April Apr 1st 2021

Seeding a Life-Changing International Genomic Insight Alliance to Treat Pediatric Epilepsy

Read More
News , Blog
Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing
Posted March Mar 31st 2021

Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing

Read More
previous 1 ...
2 3 4 5 6
... 18 next
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2021 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.